GR960300039T1 - Muscle relaxant pharmaceutical compositions - Google Patents

Muscle relaxant pharmaceutical compositions

Info

Publication number
GR960300039T1
GR960300039T1 GR960300039T GR960300039T GR960300039T1 GR 960300039 T1 GR960300039 T1 GR 960300039T1 GR 960300039 T GR960300039 T GR 960300039T GR 960300039 T GR960300039 T GR 960300039T GR 960300039 T1 GR960300039 T1 GR 960300039T1
Authority
GR
Greece
Prior art keywords
pharmaceutical compositions
muscle relaxant
tryptophan
serine
glycine
Prior art date
Application number
GR960300039T
Other languages
English (en)
Inventor
Stefano Poli
Tiziano Crimella
Ambrogio Magni
Luigi Moro
Original Assignee
Poli Ind Chimica Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11369756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR960300039(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Poli Ind Chimica Spa filed Critical Poli Ind Chimica Spa
Publication of GR960300039T1 publication Critical patent/GR960300039T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
GR960300039T 1994-10-21 1996-08-31 Muscle relaxant pharmaceutical compositions GR960300039T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942166A IT1271031B (it) 1994-10-21 1994-10-21 Composizioni farmaceutiche miorilassanti

Publications (1)

Publication Number Publication Date
GR960300039T1 true GR960300039T1 (en) 1996-08-31

Family

ID=11369756

Family Applications (2)

Application Number Title Priority Date Filing Date
GR960300039T GR960300039T1 (en) 1994-10-21 1996-08-31 Muscle relaxant pharmaceutical compositions
GR970402416T GR3024761T3 (en) 1994-10-21 1997-09-17 Muscle relaxant pharmaceutical compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
GR970402416T GR3024761T3 (en) 1994-10-21 1997-09-17 Muscle relaxant pharmaceutical compositions

Country Status (9)

Country Link
EP (1) EP0707853B1 (el)
AT (1) ATE156016T1 (el)
CA (1) CA2160938C (el)
DE (2) DE69500490T2 (el)
DK (1) DK0707853T3 (el)
ES (1) ES2088379T3 (el)
GR (2) GR960300039T1 (el)
HK (1) HK1001719A1 (el)
IT (1) IT1271031B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6911455B2 (en) 1999-12-22 2005-06-28 Smithkline Beecham Corporation Methods for preparing pharmaceutical formulations
DE60034366T2 (de) * 1999-12-22 2007-12-20 Glaxo Group Ltd., Greenford Verfahren zur herstellung pharmazeutischer formulierungen
DE102005030423A1 (de) * 2005-06-30 2007-01-04 Inresa Arzneimittel Gmbh Neue Formulierung für Vecuroniumbromid
CA2631243A1 (en) * 2005-12-08 2007-06-14 Wyeth Liposomal compositions
EP2712611A1 (en) 2012-09-27 2014-04-02 B. Braun Melsungen AG Stabilized aqueous compositions of neuromuscular blocking agents
RU2594062C2 (ru) * 2013-07-23 2016-08-10 Закрытое акционерное общество "ЭкоФармПлюс" Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом
CN107638391B (zh) * 2016-07-22 2020-10-16 海南合瑞制药股份有限公司 一种注射用苯磺顺阿曲库铵组合物
CN108676052B (zh) * 2018-08-16 2020-05-22 北京市新里程医药科技有限公司 一种罗库溴铵的制备方法及其药物组合物
CN111374942B (zh) * 2018-12-30 2022-09-13 鲁南制药集团股份有限公司 一种甾体类肌松药注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69331930T2 (de) * 1992-02-18 2003-01-09 Pharmos Corp Trockene zusammensetzungen zur herstellung von emulsionen im submikron-bereich
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity

Also Published As

Publication number Publication date
EP0707853A1 (en) 1996-04-24
DE69500490D1 (de) 1997-09-04
ES2088379T1 (es) 1996-08-16
ATE156016T1 (de) 1997-08-15
EP0707853B1 (en) 1997-07-30
HK1001719A1 (en) 1998-07-03
DE707853T1 (de) 1996-12-12
IT1271031B (it) 1997-05-26
ES2088379T3 (es) 1997-10-16
ITMI942166A0 (it) 1994-10-21
DE69500490T2 (de) 1997-12-04
CA2160938A1 (en) 1996-04-22
DK0707853T3 (da) 1998-03-02
CA2160938C (en) 2008-07-15
GR3024761T3 (en) 1997-12-31
ITMI942166A1 (it) 1996-04-21

Similar Documents

Publication Publication Date Title
IL136044A (en) 2-aminoacetamide derivatives and pharmaceutical compositions containing the same
PT792287E (pt) Analogos peptidicos da proteina basica da mielina humana
HK1039271A1 (en) Method for prevention and/or cosmetic treatment ofskin stripe and use in dermatology.
HK1043475A1 (en) Compositions and methods for treating infections using analogues of indolicidin
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
HUT73761A (en) Process for the light stabilization of sunscreen agents derived from dibenzoylmethane, light-stabilized cosmetic sunscreen compositions thus obtained, and uses thereof
DE69614681D1 (de) Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten
AU7449598A (en) Medicinal composition for prevention or treatment of hepatopathy
IL116211A0 (en) Peptide compounds pharmaceutical compositions containing the same and processes for the preparation thereof
IL106672A0 (en) 9-((substituted glycyl)amino))-6-demethyl-6-deoxytetracyclines
DE69604147T2 (de) Flüssige zuzammensetzung zur stabilisierung von aminosäure-herbiziden
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
GR3024761T3 (en) Muscle relaxant pharmaceutical compositions
HUP9900085A3 (en) Azine derivatives, of amino acids and pharmaceutical compositions containing them
MX9710252A (es) Utilizacion de al menos un peptido en una composicion cosmetica o para la preparacion de un medicamento.
IL104574A0 (en) Antitumor compositions and method of treatment
BG103632A (en) Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment
YU20050685A (sh) Poboljšanje podnošljivosti farmaceutski delotvornih beta- amino kiselina
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
CA2218643A1 (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
ATE219763T1 (de) Amid enthaltende kosmetische zusammensetzungen und neue amide
AU3494093A (en) S-lipophilic aliphatic carbonyl {n-mercaptoacyl-(amino acid or peptide)} compounds as antihypertensive agents
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition